Yaoyao Shi

Yaoyao Shi is a seasoned professional in the field of translational research and immunology, currently serving as the Translational Research Lead at Takeda Oncology since September 2022. Prior experience includes roles as a Senior Scientist in Cell Therapy Clinical Biomarker at Athenex, and as a Scientist II at Ziopharm Oncology, where efforts focused on preclinical studies for TCR-T cell therapeutics. Notably, Yaoyao Shi has contributed to clinical biomarker discovery and immune monitoring at MD Anderson Cancer Center, and conducted impactful preclinical research on antibody therapeutics during a postdoctoral fellowship at the University of Chicago Medicine. Yaoyao Shi holds a Ph.D. in Immunology from the Chinese Academy of Sciences and completed a postdoctoral fellowship in Radiation and Cellular Oncology at the University of Chicago.